In Deutschland erkranken jährlich zwischen 600 und 650 Männer an Brustkrebs. Aufgrund des geringen öffentlichen Bewusstseins und fehlender Vorsorgeuntersuchungen wird die Erkrankung aber oft erst in einem fortgeschrittenen Stadium diagnostiziert.
Literatur
Neumann JL. Brustkrebs des Mannes. Frauenarzt. 2014; 55: 582–7
Giordano SH et al. Breast carcinoma in men: a population-based study. Cancer. 2004; 101: 51–7
Robert Koch-Institut (Hrsg.) und die Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V. (Hrsg.). Krebs in Deutschland 2011/2012. 10. Ausg. Berlin, 2015
Tumorregister Munchen (TRM). ICD-10 C50: Mammakarzinom (Ma.nner) Survival. 2017. https://www.tumorregister-muenchen.de/facts/specific_analysis.php
Tumorregister Munchen (TRM). ICD-10 C50: Mammakarzinom (Frauen) Survival. 2017. https://www.tumorregister-muenchen.de/facts/specific_analysis.php
Brinton LA et al. Anthropometric and hormonal risk factors for male breast cancer: male breast cancer pooling project results. J Natl Cancer Inst. 2014; 106: djt465
Obenauer S. Das männliche Mammakarzinom. Senologie. 2013; 10: 83–5
AGO Breast Committee. Diagnosis and Treatment of Patients with Primary and Metastatic Breast Cancer. Recommendations 2018
Ottini L et al. Male breast cancer. Critical reviews in oncology/hematology. 2010; 73: 141–55
Nilsson C et al. Molecular subtyping of male breast cancer using alternative definitions and its prognostic impact. Acta Oncologica. 2013; 52: 102–9
De Cicco C et al. Sentinel node biopsy in male breast cancer. Nuclear medicine communications. 2004; 25: 139–43
Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft DK, AWMF). S3-Leitlinie Fru.herkennung, Diagnose, Therapie und Nachsorge des Mammakarzinoms, Konsultationsfassung 0.4.0, 2017 AWMF Registernummer: 032- 045OL. 2017
Cutuli B. Strategies in treating male breast cancer. Expert opinion on pharmacotherapy. 2007; 8: 193–202
Fogh S et al. Use of tamoxifen with postsurgical irradiation may improve survival in estrogen and progesterone receptor-positive male breast cancer. Clinical breast cancer. 2011; 11: 39–45
Eggemann H et al. Adjuvant therapy with tamoxifen compared to aromatase inhibitors for 257 male breast cancer patients. Breast cancer research and treatment. 2013; 137: 465–70
Kowalski C et al. Health-related quality of life in male breast cancer patients. Breast cancer research and treatment. 2012; 133: 753–7
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Würstlein, R., Hesse, A., König, A. et al. Tastbefund an der Brust: Auch bei Männern immer abklären!. Uro-News 22, 26–29 (2018). https://doi.org/10.1007/s00092-018-1990-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00092-018-1990-3